Anavex Life Sciences Corp (AVXL)

[Gator328]

My guess is that Anavex wants to have the data peer-reviewed and published.

I'm more interested in what caused the delay than what the specific data metrics look like in P2. If the drug works, and it can pass a P3 approval, that's all that matters. Markets only care about approval or rejection, the degree to which a drug is successful or not isn't nearly as important.